• 2025 headwinds from tariffs, immigration changes and interest rates appear to have abated. NEWS RELEASE NCR Atleos Corporation Reports Strong Results in 2025 In a Separate Press Release, Atleos Announces Entry into Definitive Agreement to be Acquired by The Brink's Company ATLANTA, February 26, 2026 - NCR Atleos Corporation (NYSE: NATL) ("Atleos"), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today reported fourth quarter and full year 2025 resul ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______. Commission File Number 001-38943 Personalis, Inc. (Exact name of Registrant as specified in its Charter) Delaware 27-5411038 (State or other jurisdiction ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 23, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-27130 NetApp, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer inc ...

Exhibit 99.1 National CineMedia, Inc. Reports Results for Fiscal Fourth Quarter and Full Year 2025 Fourth quarter operating income increases year over year and fourth quarter adjusted OIBDA exceeds guidance Fourth quarter revenue growth of 8% outpaced attendance as NCM attracted greater advertiser demand Centennial, Colo. - February 26, 2026 - National CineMedia, Inc. (NASDAQ: NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema adverti ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-34723 AMERICOLD REALTY TRUST, INC. (Exact name of registrant as specified in its charter) Maryland 93-0295215 (State or other jurisdiction of i ...

Exhibit 99.1 FOR RELEASE: CONTACT: New Hartford, NY, February 26, 2026 Christopher R. Byrnes (315) 743-8376 chris_byrnes@partech.com, www.partech.com PAR TECHNOLOGY CORPORATION ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS New Hartford, NY - February 26, 2026 -- PAR Technology Corporation (NYSE: PAR) ("PAR Technology" or the "Company") today announced its financial results for the fourth quarter and year ended December 31, 2025. | (in millions, except % and per share | GAAP | | | Non-GAAP | | (1) | | ...

Exhibit 99.1 OneStream Announces Fourth Quarter and Fiscal Year 2025 Financial Results BIRMINGHAM, Mich., OneStream, Inc. (Nasdaq: OS), the leading enterprise Finance management platform that modernizes the Office of the CFO by unifying core finance and operational functions -- including financial close, consolidation, reporting, planning and forecasting -- today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Fiscal Year 2 ...

Exhibit 99.1 Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights SAN DIEGO, February 26, 2026 – Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update. "The past year marked a period of significant execution and progress for Janux as we continu ...

Exhibit 99.1 Aeva Reports Fourth Quarter and Full Year 2025 Results 2026 Financial Outlook • Revenue in the range of $30 million to $36 million, representing growth of approximately 70% to 100% year-over-year Awarded Major Global Production Contract from Top 10 Passenger OEM Selected by Top 5 Passenger OEM for Global Vehicle Development Program Nvidia Selected Aeva as Reference LiDAR Sensor for DRIVE Hyperion Platform Doubled Revenue in 2025 Driven by Scaling Volume and New Markets Expansion MOUNTAIN VIEW, ...

Exhibit 99.1 Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones Initial Phase 1 data of zovegalisib in PIK3CA-driven vascular anomalies expected to be announced in first half of 2026 Breast cancer triplet data and frontline Phase 3 plans expected to be announced in 2026 Initial Phase 1/2 data of zovegalisib + fulvestrant at 400mg BID fed (Phase 3 dose) in CDK4/6-experienced patients to be presented at ESMO TAT on March 16, 2026 Approximate ...